BRIEF-OncoSec says presents preclinical data demonstrating improved systemic anti-tumor response following modifications to il-12 gene delivery therapy
BRIEF-LightInTheBox Holding Co Q1 non-GAAP net loss per ADS $0.01
* Says total orders of product sales were 1.6 million for Q1 of 2017, compared with 1.7 million in same quarter of 2016